These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 28031950)

  • 1. Improving public awareness and outcomes for oral cancer.
    Poh CF
    Future Sci OA; 2016 Mar; 2(1):FSO103. PubMed ID: 28031950
    [No Abstract]   [Full Text] [Related]  

  • 2. What could the future hold for treatment sequencing in cancer medicine? An interview with Angela Märten.
    Märten A; Jenkins R
    Future Oncol; 2019 Sep; 15(25):2891-2893. PubMed ID: 31424270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life as an early career researcher: interview with Catherine Martel.
    Martel C
    Future Sci OA; 2016 Mar; 2(1):FSO108. PubMed ID: 28031952
    [No Abstract]   [Full Text] [Related]  

  • 4. Advanced prostate cancer: Every Voice Matters.
    Payne H; Westcott G
    Future Oncol; 2015; 11(12):1711-3. PubMed ID: 26075438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of vasoactive intestinal peptide in neuroprotection: Professor Illana Gozes is interviewed by Emma Quigley.
    Gozes I
    Expert Opin Ther Targets; 2007 Jun; 11(6):733-6. PubMed ID: 17504011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of multiple myeloma: the impact of ixazomib's approval in Canada.
    Reece DE
    Int J Hematol Oncol; 2016 Nov; 5(3):97-99. PubMed ID: 30302208
    [No Abstract]   [Full Text] [Related]  

  • 7. Addressing future challenges for cancer services: part II.
    Maher J; Radford G
    Future Oncol; 2016 Feb; 12(4):445-9. PubMed ID: 26846998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring liver physiology, pathology, TGF-β, EMT, stemness and new developments in liver cancer.
    Fabregat I
    Hepat Oncol; 2017 Jan; 4(1):9-13. PubMed ID: 30191049
    [No Abstract]   [Full Text] [Related]  

  • 9. AURA3 trial: does Tagrisso (osimertinib) have the potential to become the new standard of care for second-line treatment of patients with
    Papadimitrakopoulou VA
    Lung Cancer Manag; 2016 Dec; 5(4):159-162. PubMed ID: 30643560
    [No Abstract]   [Full Text] [Related]  

  • 10. Interview with Rima Rozen.
    Rozen R
    Pharmacogenomics; 2008 Sep; 9(9):1187-90. PubMed ID: 18781845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction of our new associate editor.
    Desjardins A; Gunawardana R
    CNS Oncol; 2014; 3(5):327-8. PubMed ID: 25363004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studying microbial pathogenesis and bacterial diseases. Interview by Hannah Branch.
    Finlay BB
    Future Microbiol; 2013 Jun; 8(6):709-10. PubMed ID: 23701328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An interview with Julie Vose: where is oncology heading?
    Vose JM; Westcott G
    Future Oncol; 2015; 11(20):2803-5. PubMed ID: 26358047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interview with a quality leader--Karen Davis, executive director of The Commonwealth Fund. Interview by Lecia A. Albright.
    Davis K
    J Healthc Qual; 2009; 31(2):5-9. PubMed ID: 19350874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Agents in Cancer Treatment: Meeting the Patients' Needs to Ensure Medication Adherence.
    Kav S
    Asia Pac J Oncol Nurs; 2017; 4(4):273-274. PubMed ID: 28966953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addressing future challenges for cancer services: part I.
    Maher J; Radford G
    Future Oncol; 2016 Feb; 12(4):439-43. PubMed ID: 26846997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-acquired AIDS in Taiwan.
    Yao C; Wang WW; Chung YM; Su YL; Liu CY; Chen YM
    J Formos Med Assoc; 1996 Jan; 95(1):51-5. PubMed ID: 8640096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure therapy: drugs, genes or stem cells?: by Caroline Telfer.
    Harding S
    Future Cardiol; 2013 Sep; 9(5):629-33. PubMed ID: 24020663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Discussion with Dr. Natasha Kekre, Hematologist and Clinician Scientist.
    Yuan AT; Kekre N
    Clin Invest Med; 2024 Mar; 47(1):1-3. PubMed ID: 38546382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.